ARTS II

ARTS II

Arterial Revascularization Therapy Study part II. A trial comparing the sirolimus-eluting Bx Velocity® Balloon expandable stent in patients with multivessel disease, ischaemia, and no prior coronary interventions.
Primary endpoint 1-year major acute coronary and cerebrovascular events (MACCE) compared with the 1-year MACCE of ARTS I.
Conclusion MACCE is 3% in ARTS II compared to 4% with CABG and 8% with percutaneous coronary intervention in ARTS I.
References in periodicals archive ?
ARTS l'in baypas ve CMS grubu ile ISS uygulanan yeni 225 hastanin karsilastirildigi ARTS II calismasinda major kardiyovaskuler olaylarda fark saptanmazken, bir yilda diger sonuclarda da fark yoktu (31).
The CYPHER(R) Stent results in the diabetic population of the ARTS II Study showed no significant difference in major adverse cardiac and cerebrovascular events (MACCE) compared to the CABG arm of the ARTS I Study (27.
The superiority of stenting with sirolimus-eluting stents in ARTS II contrasted with the results of the bare-metal-stent arm of ARTS I.
eVerge[TM] also includes ARTS II that operates in both digital and analog modes to alert users when they are no longer in range to communicate.
The late-breaking clinical trial program will include three-year results in the diabetic patient population subgroup from the ARTS II Study, which compares the CYPHER(R) Sirolimus-eluting Coronary Stent versus bypass surgery in patients with multivessel coronary disease.
Sponsored by Cordis Corporation, the ARTS II Study includes 607 patients from 45 European centres treated with the CYPHER(R) Stent.
These new findings from the ARTS II Bifurcation Sub-Analysis were presented today at the American Heart Association's Scientific Sessions.
Micro-EARTS systems are installed at Nellis Air Force Base, Anchorage Air Route Traffic Control Center, San Juan CERAP, Fort Polk ARTS II Facility, White Sands Missile Range, Guam CERAP, and Honolulu CERAP, as well as the William J.
Other noteworthy presentations include a new meta-analysis of CYPHER(R) Stent versus Taxus Stent clinical trials; a detailed analysis of the cost-effectiveness of the CYPHER(R) Stent versus coronary artery bypass grafting (CABG) from the ARTS I and ARTS II data; along with results from the SIRIUS 2.
Full browser ?